Mayne Pharma Group (AU:MYX) has released an update.
Mayne Pharma Group is set to hold its 2024 Annual General Meeting on November 21, offering shareholders a chance to engage with company leaders, discuss management strategies, and vote on key resolutions. The meeting will take place both in-person in Melbourne and online, making it accessible for a broader audience. Investors can look forward to discussions on financial reports, director re-elections, and incentive grants for the CEO.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.
